Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$47.4M
+20.0% from 2023
Prescriptions
3,395
$13,966.92 per claim
Patients
562
664 prescribers
Total spending, 2024
$47.4M
$84,373.11 per patient
Medicare prescription drug plans paid $47.4M for Tavalisse in 2024, for 3,395 prescriptions and refills to 562 patients (up 20.0% from 2023). The average cost per claim was $13,966.92.
California had the highest Medicare cost for Tavalisse in 2024: $6.1M for 428 claims, followed by New York ($4.0M).
Shahzaib Nabi, hematology-oncology in Brooklyn, NY, had the highest Medicare cost for Tavalisse in 2024: 30 claims costing $446K.
Tavalisse is made by Rigel Pharmaceuticals, Inc. (RIGL), listed in the Medicare spending data as Rigel Pharmaceu.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Shahzaib Nabi Brooklyn, NY | Hematology-Oncology | 30 | Under 11 | $446K |
| Ying Zhu Charleston, SC | Hematology-Oncology | 25 | Under 11 | $372K |
| Ester B Pollard |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 522 | 2,542 | 459 | $32.4M |
| 2023 | 561 | 2,895 | 486 | $39.5M |
| 2024 | 664 | 3,395 | 562 | $47.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 29 |
| Under 11 |
| $346K |
| Eriko Nakajima Downey, CA | Physician Assistant | 19 | Under 11 | $278K |
| 1407859259 | Hematology-Oncology | 17 | Under 11 | $253K |
| Carlos S Madamba Philadelphia, PA | Hematology-Oncology | 17 | Under 11 | $241K |
| Lori J Maness-Harris Omaha, NE | Hematology | 18 | Under 11 | $240K |
| Gustavo A Cadavid Hialeah, FL | Hematology-Oncology | 16 | Under 11 | $237K |
| Livia T Hegerova Seattle, WA | Hematology-Oncology | 14 | Under 11 | $209K |
| Jennifer E Girard Ann Arbor, MI | Hematology | 16 | Under 11 | $209K |
| David J Mooney Birmingham, AL | Hematology-Oncology | 14 | Under 11 | $206K |
| Jennifer S Mead Boston, MA | Physician Assistant | 14 | Under 11 | $205K |
| Syed E Ahmed Sebring, FL | Medical Oncology | 14 | Under 11 | $204K |
| Andrew E Fintel Salem, VA | Hematology-Oncology | 14 | Under 11 | $202K |
| Luis G Sepulveda-Maldonado Ponce, PR | Hematology | 13 | Under 11 | $194K |
| Upama Giri Fairfax, VA | Hematology-Oncology | 13 | Under 11 | $194K |
| Robert J Kribs Jr. Kansas City, KS | Hematology | 14 | Under 11 | $194K |
| Adam R Schmuckler Columbia, MD | Physician Assistant | 13 | Under 11 | $193K |
| Nelson A Matos-Fernandez Santa Isabel, PR | Hematology-Oncology | 13 | Under 11 | $193K |
| Ashrei Bayewitz Mineola, NY | Hematology-Oncology | 13 | Under 11 | $193K |
| Janessa J Hawara Rancho Mirage, CA | Physician Assistant | 13 | Under 11 | $192K |
| Abdullateef Abdulkareem Lancaster, PA | Hematology-Oncology | 13 | Under 11 | $192K |
| Jeffrey R Zweig Pleasant Hill, CA | Hematology-Oncology | 16 | Under 11 | $191K |
| Michael B Glowalla Los Angeles, CA | Internal Medicine | 12 | Under 11 | $191K |
| Mian K Khalid Baltimore, MD | Hematology | 12 | Under 11 | $191K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Rigel Pharmaceu RIGL | 3,395 | $47.4M |